期刊文献+

早发性帕金森病患者线粒体DNA部分点突变的研究 被引量:5

Mitochondrial DNA partly point mutations in praecox Parkinson's disease
原文传递
导出
摘要 目的 验证线粒体DNA点突变与早发性帕金森病 (PPD)的相关性 ,并了解中国人线粒体DNA点突变特点。方法 用聚合酶链反应 (PCR)、斑点杂交、放射显影定性方法对 4 0例PPD患者及 4 8名健康对照组A4 336C、G5 4 6 0A、A10 398G、A13780G突变点进行检测 ,对 2 0例PPD组和 2 0例对照组碱基位点 10 2 5 6~ 10 5 77线粒体DNA片段测序。结果 PPD组A10 398G、G5 4 6 0A、A4 336C、A13780G ,4个位点的突变率均高于对照组 ,而且PPD组A10 398G突变率 (5 0 0 % )显著高于对照组 (14 6 % ) (P =0 0 0 0 1) ;其他 3个突变点PPD组的突变率与对照组比较差异无显著意义 ;新发现碱基位点 10 4 0 0C/T多态性。结论 线粒体DNA突变与PPD的发病存在相关性 ,A10 398G突变很可能是PPD发病的一个重要原因 ;中国人线粒体DNA存在 10 4 0 0C/T多态性和PPD患者A10 398G高突变率 (5 0 0 % ) Objective To test the association between mitochondrial DNA(mtDNA) point mutations and praecox Parkinson's disease (PPD),and to investigate the characteristics of mtDNA mutations in Chinese patients with PPD. Methods Screening mtDNA A4336C, G5460A,A10398G,A13780G point mutations in 40 patients with PPD and 48 in control group was carried out by using Polymerase Chain Reaction (PCR), dot blotting, radiant developing. And sequencing was given to the nucleotide position (np)10256~np10577mtDNA of 20 patients with PPD and 20 subjects in control group.Results Out of the 40 patients with PPD, 20 (50%)had A10398G mutation. 6 (15%) had G5460A, 5(12.5%) had A13780G, 2 (5%)had A4336C, 19 (47.5%)had C10400T mutation. Out of the 48 controls, 7(14.6%) had A10398G, 24.2% had G5460A, 1 (2.1%)had A13780G and 20 (41.7%)had C10400T, but no any A4336C mutation was found in the controls. Thus, the ratios of A10398G,G5460A,A4336C,A13780G in patients with PPD were separately higher than those in the control group. Moreover significant difference was found in A10398G point mutation (P<0.01) . No significant differences were found in the other 3 point mutations; and a new synonymous mutation--C10400T was found in the study,showing that the np10400C/T single-nucleotide polymorphism (SNP) of mtDNA could be found in Chinese.Conclusions Our results suggest there exists association between mtDNA missense mutations and PPD: the A10398G missense mutation might possibly be one of the contributing factors leading to PPD. The high ratios of A10398G in PPD and the np10400C/T SNP should be two characteristics of Chinese mtDNA.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2004年第5期409-412,共4页 Chinese Journal of Neurology
基金 广西自然科学基金资助项目 (桂科自 0 3 3 90 48)
关键词 PPD 对照组 患者 点突变 早发性帕金森病 线粒体DNA 发病 碱基 位点 测序 Parkinson disease DNA, mitochodrial Point mutation
  • 相关文献

参考文献11

  • 1Schapira AHV,Cooper JW,Dexter D,et al.Mitochondrial complex I deficiency in Parkinson's disease.J Neurol,1989,26: 719-723.
  • 2Aomi Y,Chen CS,Nakada K,et al.Cytoplasmic transfer of platelet mtDNA-less Hela cells restores complete mitochondrial respiratory function.Biochem Biophys Res Commun,2001,280:265-273.
  • 3Vives-Bauza C,Andreu Al,Manfredi G,et al.Sequence analysis of the entire mitochondrial genome in parkinson's disease.Biochem Biophys Res Commun,2002,290:1593-1601.
  • 4Simon DK,Mayeux R,Marker K,et al.Mitochondrial DNA mutations in complex I and tRNA genes in parkinson's disease.Neurology,2000,54: 703-709.
  • 5Human mitochondrial DNA revised Cambridge reference sequence Available from: URL:http://www.mitomap.com.
  • 6Anderson S,Bankier AT,Barrell BG,et al.Sequence and organization of the human mitochondrial genome.Nature,1981,290:457-465.
  • 7Chinnery PF,Schon EA.Mitochondria.J Neurol Neurosurg Psychiatry,2003,74:1188-1199.
  • 8Tretter L,Sipos I,Adam-Vizi V.Initiation of neuronal damage by complex I deficiency and oxidative stress in Parkinson's disease.Neurochem Res,2004,29: 569-577.
  • 9Orth M,Schapire AH.Mitochondrial involvement in parkinson's disease.Neurochem Int,2002,40:533-541.
  • 10Jenner P,Olanow CW.Understanding cell death in parkinson's disease.Ann Neurol,1998,44 (3 Suppl 1):S72-S84.

同被引文献95

  • 1金淼,焦劲松,顾卫红,王康,杜皓萍,王晓工,王国相.常染色体隐性遗传早发型帕金森病家系的DJ-1基因研究[J].中日友好医院学报,2006,20(3):161-164. 被引量:2
  • 2彭蓉,陈文军,吴妍,刘鸣,赖晓辉,张锦红,袁光固,苟婴茹,李涛,王英成.parkin基因多态性与四川地区散发性帕金森病的相关性研究[J].中华医学遗传学杂志,2007,24(1):38-41. 被引量:1
  • 3van der Walt J M, Nicodemus K K, Martin E R. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease[J]. Am J Hum Genet, 2003,72:804-811.
  • 4Ghezzi D, Marelli C, Achilli A. Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians[J]. Eur J Hum Genet, 2005,13:748-752.
  • 5Meara J, Bhowmick B K, Hobson P. Accuracy of diagnosis in patients with presumed Parkingson's diease[J]. Age Ageing, 1999,28: 99-102.
  • 6Vives-Bauza C, Andreu A, Manfredi G, et al. Sequence analysis of the entire mitochondrial genome in parkinson's disease [J]. Biochem Biophys Res Commtm, 2002,290:1593-1601.
  • 7Lenaz G, Bovina C, D'Aurelio M. Role of mirochondria in oxidative stress and aging[J]. Ann N Y Acad Sci, 2002,959:199-213.
  • 8Wei Y H, Lee H C. Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes in aging[J]. Exp Biol Med, 2002,227(9:)671-82.
  • 9Mayr W U, Rodel G, Henneberg A. mitochondrial tRNA(Gln) and tRNA(Thr) gene varia in Parkinsons diseaes[J]. Eur J Med Res, 1997,2(3): 111-113.
  • 10Torroni A, Huoponen K, Francalacci P. Classification of European mtDNA from an analysis of three European poplations [J]. Genet Soc Amer, 1996,144:1835-1850.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部